MedPath
NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

国药准字H20223059

January 30, 2022

Drug Information

盐酸莫西沙星滴眼液

眼用制剂

0.5%(5ml:25mg)(按C₂₁H₂₄FN₃O₄计)

化学药品

January 30, 2022

Company Information

Applicant Company

长春市经济开发区会展大街21号

Manufacturing Company

湖北省武汉市庙山开发区阳光大道阳光工业园;湖北省枝江经济开发区姚家港循环经济示范园石宝山大道

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath